BOM Health: Five Checks that Protect Your Product From Lifecycle Risk

line

What is BOM health, and why does it matter?

A Bill of Materials, or BOM, is the complete list of parts, components, and materials required to manufacture a product. In electronics manufacturing, it is one of the most important documents behind a successful build. It tells your manufacturing partner what needs to be sourced, assembled, tested, and supported over time.

“BOM health” is a measure of how complete, current, and manufacturable your Bill of Materials is. For engineering managers, this matters because BOM issues often become engineering problems. An end-of-life component may require a redesign; an unavailable part may need testing and approval of an alternative, and a long lead-time item can create delays.

BOM health is closely linked to design for manufacture (DFM). The earlier a manufacturing partner reviews the BOM alongside the design intent, the easier it is to identify sourcing, lifecycle, and manufacturability risks before they become production constraints.

For the wider business, BOM health is also a commercial-risk issue. Poor lifecycle visibility can lead to cost spikes, margin pressure, production delays, and unexpected rework.

In contrast, proactive BOM lifecycle management helps protect product continuity, reduce stress through production, and support better decisions before a small component issue becomes a major delivery problem.

line

Why BOM health is more than a parts list

A BOM may look complete because every required component is listed, but that does not always mean the product is ready for reliable production. The real question is whether those parts can be sourced consistently, at an acceptable cost, and without creating avoidable engineering or delivery risk.

A few common terms it’s useful to understand:

  • Active
    An active component is still in production and generally available for use in new designs. This is usually the preferred lifecycle status, but it is not a guarantee that the part is risk free. An active part may still have long lead times, limited suppliers, price volatility, or allocation issues. While lifecycle status is important, it is only one part of BOM health.
  • NRND – Not Recommended for New Designs
    This means the component may still be available, but the manufacturer is signalling that it should not be used in new products or redesigns. It may be nearing the later stages of its lifecycle, or there may be a newer replacement available. NRND does not always mean there is an immediate supply problem, but it is a warning sign. For engineering teams, it is worth reviewing whether the part should remain in the design, whether an alternative should be qualified, or whether a redesign should be planned before the issue becomes urgent.
  • EOL – End of Life
    An EOL component is being discontinued or has already been discontinued by the manufacturer. Once a part reaches this stage, supply may become limited, pricing may increase, and the product may become harder to manufacture reliably. EOL risk can have a direct engineering and commercial impact. It may require a last-time buy, an approved substitute, or a redesign. If the component is critical to the product, an EOL notice can affect production continuity, customer delivery commitments, and long-term product support.
  • Single-source risk
    A single-source component is a part that can only be purchased from one manufacturer, or where there is no approved alternative already in place. This can create risk if that supplier has production constraints, changes the part, increases pricing, or discontinues it. In some cases, the part may be technically available, but not available quickly enough to support production schedules. For engineering teams, single-source risk can become a design issue. If there is no drop-in alternative, a shortage or discontinuation may require redesign, testing, and approval work.
  • Lead time volatility
    Lead time volatility refers to changes in how long it takes to source a component. A part that usually takes six weeks to arrive may suddenly move to 20, 30, or even 40-plus weeks, depending on global supply, allocation, demand shifts, or manufacturer constraints. That kind of change can affect ‘new product introduction’ (NPI) timing, production planning, delivery commitments, and working capital. Lead time volatility is one reason BOM health should not be treated as a one-off check. A BOM that was low risk six months ago may look very different today.
line

Five lifecycle checks that protect your product

Not every contract manufacturer offers a BOM health check as part of their service; at ASL it is an essential part of how we operate.

When ASL receives an initial Request for Quote (RFQ), the Component Engineering team runs a BOM health check as part of the costing process to identify any issues, which are then fed back to the customer. This is especially important for new product introduction (NPI), but also for established products. We typically run in-production health checks every 6 months and are useful for reconfirming the BOM cost.

Whoever you are working with, make sure your contract manufacturer is checking your BOM on a regular basis as pricing and availability change regularly.

These five lifecycle checks are a practical starting point to help identify risk - before it affects your production, cost, or delivery.

1. Check lifecycle status before production decisions are locked in

The first check is to review the lifecycle status of each component in the BOM, identifying which parts are active, which are NRND, and which are EOL. This helps mitigate the risk of a product moving into production with hidden lifecycle problems already built in.

We recently received a Request for Quote (RFQ) from a company we had not worked with or quoted before. As part of the RFQ process a BOM health check was run which highlighted several components that were already marked as EOLor NRND which the company was unaware of. They were able to modify their design to mitigate the issue.

At ASL we recommend reviewing lifecycle status before production decisions are locked in, during the DFM and NPI stages. This allows engineering teams time to make controlled decisions, rather than reacting under pressure once a part becomes unavailable.

2. Confirm and approve alternatives before they are needed

As part of the design process identifying and approving second-source components is important. Having approved second-sources gives your manufacturer an option should the primary part be unavailable.

Second-source alternatives should be technically suitable, ideally with the same or a very similar footprint in order to minimise issues during manufacture.

It should be noted that often second-sources can incur additional cost, which can be managed by your contract manufacturer using PPV (Purchase Price Variation).

The risk of not having approved alternatives is that production may be delayed while engineering teams confirm whether another part can be used.

We advise building second-source component thinking into designs early so that when BOM health checks are carried out all options can be checked.

Some components, typically microprocessors, FPGAs and power supplies are often single source. For these single source parts, alternative strategies are required to minimise supply chain risk.

3. Identify single-source dependencies early

As mentioned above, single-source parts are often unavoidable, but the risk should be visible and understood and mitigated. No one wants one component to hold up an entire production build, even if all other components are available.

At ASL, we routinely flag single-source parts in the BOM and work with customers to manage the associated risk. Options may include holding strategic stock for single-source, long lead-time, or last-time-buy components. This can be managed through a Manufacturing Services Agreement (MSA), which defines the agreed process for managing the customer’s product builds, including how single-source and long lead-time components will be monitored and managed.

4. Monitor lead time and risk

Another useful check is to review lead times on components in a BOM and to highlight any risk to supply. An example is when a component is available, but has a lead-time which is outside the expected manufacturing window. This will add delay to NPI or production builds and may entail purchasing stock on the open market to meet demand which can be costly.

At ASL we work with customers to monitor lead times regularly, especially for critical components. This gives them time to adjust forecasts, place orders earlier, review alternatives or discuss stock-holding options before supply becomes a constraint.

5. Review cost movement before it becomes margin pressure

The final BOM health check is to look at cost movement across the BOM.

Over time component pricing can change due to several factors – including availability, demand, supplier price increases, and currency movements. The risk of these is margin erosion.

At ASL we manage the cost movement using two methods:

  1. Every six months the Component Engineering and Purchasing team at ASL undertake a requote of production BOMs to ensure all pricing remains accurate and up to date. If there is a discrepancy, the customer will be given a new quotation
  2. For BOM cost movements within the six month window, ASL use PPV (Purchase Price Variation) to manage any increases or decreases. This is rolled up at the end of a production build and the difference noted on the invoice.

At ASL, we aim to discuss significant price variations with customers prior to parts being purchased, so we avoid any unexpected surprises.

line

To Summarise

At ASL we treat BOM health as both a technical and commercial review, and something we work closely with our customers to monitor.

Dean Hunt, our New Business Development Manager says:

“A strong BOM health process gives engineering, procurement and product teams a shared view of risk. It helps identify issues early, before they become urgent production problems.

More importantly, it shifts BOM management from a reactive purchasing task to a proactive lifecycle discipline that protects product continuity, cost control and delivery confidence.”

In a strong manufacturing partnership, BOM health sits alongside DFM (Design for Manufacture) as the cornerstone of a successful product.

Ensure your manufacturing partner is carrying out these checks:

  1. Check lifecycle status before production decisions are locked in.
  2. Identify single-source dependencies early and mitigate their impact.
  3. Confirm and approve alternatives before they are needed – second-source components can be gold.
  4. Monitor lead time and risk and make sure you have a plan if lead-times increase.
  5. Review cost movement before it becomes margin pressure

At ASL, we believe that good BOM health management is a shared partnership process between us and our customers. It includes lifecycle monitoring, supplier engagement, lead time review, alternative part planning, and regular communication between engineering, procurement and production teams.

For companies working with New Zealand-based contract manufacturers, this partnership model can be especially valuable. Local engagement during the design phase makes conversations about design intent, supply constraints, approved alternatives, and production schedules easier and more effective. Rather than treating BOM issues as isolated purchasing problems, manufacturers and customers can work together to manage them as part of the wider product lifecycle.

If you are unsure about the lifecycle health of your current BOM, ASL would be happy to review it with you and identify any potential risks.

It is also useful to discuss this internally with your engineering, procurement, or supply chain colleagues, especially if you are preparing NPI, scaling production, or managing an established product with long-term supply requirements.

line

Get in touch

If you want help to scale and a partner who acts like part of your team, get in touch - we'd love to chat.